SEC Form D · filed March 2, 2021
Vividion Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Jakob E. Loven · San Diego, CADirectorBenjamin L. Cravatt · San Diego, CADirectorKristina L. Burow · San Diego, CADirectorRichard L. Heyman · San Diego, CADirectorJohn L. Clarke · San Diego, CADirectorThomas E. Woiwode · San Diego, CADirectorBryan Staff · NEW YORK, NYDirectorDavid Mrazik · NEW YORK, NYDirectorMatt Brinker · NEW YORK, NYDirectorVictor Patterson · SAN FRANCISCO, CADirectorAmit Patel · SAN FRANCISCO, CADirectorTim Bello · NEW YORK, NYDirectorJeffrey Hatfield · Fort Washington, PAExec · DirectorPatricia L. Allen · Waltham, MAExecThomas E. Daniel · San Diego, CADirectorCarmichael J. Roberts · Boston, MADirectorAdam Sharkawy · Boston, MADirectorChad Milam · Culver City, CADirectorVasa Babic · Culver City, CADirectorDavid Ward · Culver City, CADirectorHuanhuan Gilmore · Culver City, CADirectorJeffrey Hatfield · San Diego, CAExec · DirectorPatricia L. Allen · Waltham, MAExecThomas E. Daniel · San Diego, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗